Agilus Diagnostics has launched an automated molecular diagnostics platform capable of detecting key cancer-related genetic mutations within 2.5 to 3 hours, reducing the time required for biomarker ...

During the 2026 NCCN Annual Conference, Sandy Srinivas, MD, emphasized that HRR mutation testing in advanced prostate cancer is underutilized. In an interview during the 2026 NCCN Annual Conference, ...

Tests that pass don't prove anything. A test suite can have 100% coverage and still miss real bugs. Mutation testing answers: if I break this code, do the tests notice? agent-mutator introduces small ...

Lee Zeldin, the E.P.A. administrator, revived a plan created during the first Trump administration to end the testing of chemicals on mammals. By Lisa Friedman The Environmental Protection Agency will ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

MOBSTA is a robustness testing tool for ROS that tests autonomous systems under realistic but rare conditions that are not represented in training data and difficult to replicate during field testing.

Panelists discuss the expanding array of treatment options for metastatic hormone receptor–positive breast cancer, emphasizing the critical role of molecular testing—both tissue biopsy and circulating ...

A team led by Rutgers University-New Brunswick engineers has developed a portable device capable of detecting rare genetic mutations from a single drop of blood. The instrument, described in a study ...

The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...